<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CCHR International &#187; Physican Payment Sunshine Act</title>
	<atom:link href="http://www.cchrint.org/tag/physican-payment-sunshine-act/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.cchrint.org</link>
	<description>Human Rights organization</description>
	<lastBuildDate>Tue, 07 Feb 2012 18:46:12 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>U.S. Sen Grassley-Demanding transparency for Pharma funds paid to doctors, researchers, patient &#8216;advocacy&#8217; groups</title>
		<link>http://www.cchrint.org/2009/11/19/grassley-demands-transparency-for-pharma-advocacy-groups/</link>
		<comments>http://www.cchrint.org/2009/11/19/grassley-demands-transparency-for-pharma-advocacy-groups/#comments</comments>
		<pubDate>Thu, 19 Nov 2009 18:57:31 +0000</pubDate>
		<dc:creator>cchrint</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[advocacy groups]]></category>
		<category><![CDATA[conflicts of interest]]></category>
		<category><![CDATA[ghost writing]]></category>
		<category><![CDATA[medical schools]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Physican Payment Sunshine Act]]></category>
		<category><![CDATA[Senate Kohl]]></category>
		<category><![CDATA[senator grassley]]></category>
		<category><![CDATA[transparency]]></category>

		<guid isPermaLink="false">http://www.cchrint.org/?p=2991</guid>
		<description><![CDATA[Senator Chuck Grassley has asked leading medical schools to describe their policies on ghostwriting as part of his continuing effort to shed light on financial ties between the pharmaceutical industry and medical professionals. “I’m interested in transparency, and academic institutions play an important role in establishing adequate and meaningful disclosure," he said. Grassley also has conducted oversight and sought disclosure with physicians, continuing medical education and the patient advocacy community.]]></description>
			<content:encoded><![CDATA[<div class="tweetmeme_button" style="float: left; margin-right: 10px;">
			<a href="http://api.tweetmeme.com/share?url=http%3A%2F%2Fwww.cchrint.org%2F2009%2F11%2F19%2Fgrassley-demands-transparency-for-pharma-advocacy-groups%2F"><br />
				<img src="http://api.tweetmeme.com/imagebutton.gif?url=http%3A%2F%2Fwww.cchrint.org%2F2009%2F11%2F19%2Fgrassley-demands-transparency-for-pharma-advocacy-groups%2F&amp;source=cchrint&amp;style=normal&amp;b=2" height="61" width="50" /><br />
			</a>
		</div>
<p>IowaPolitics.com<br />
November 19, 2009</p>
<p>WASHINGTON &#8212; Senator Chuck Grassley has asked leading medical schools to describe their policies on ghostwriting as part of his continuing effort to shed light on financial ties between the pharmaceutical industry and medical professionals.</p>
<p>“I’m interested in transparency, and academic institutions play an important role in establishing adequate and meaningful disclosure. Letting the sun shine in and making information public is basic to building people’s confidence in medical research and the practice of medicine,” Grassley said.</p>
<p>Last July, Grassley wrote to eight leading medical journals to ask the same kinds of questions he’s presented to the medical schools. Prior to that, he asked two major drug companies about allegations that they hired ghostwriters to draft articles promoting company products and seek academics to sign on as primary authors.</p>
<p>Grassley also has conducted oversight and sought disclosure with physicians, continuing medical education and the patient advocacy community. He has worked to expose cases where there was vast disparity between drug-company payments received and reported by leading medical researchers. The National Institutes of Health is working on new disclosure guidelines for federal grant recipients in response to Grassley’s work.</p>
<p>In January, Grassley and Senator Herb Kohl introduced, for the second time, the Physician Payments Sunshine Act. The legislation would require annual public reporting by drug, device and biologic manufacturers of payments made to physicians nationwide. It was included in the health care reform bill passed in October by the Senate Committee on Finance.</p>
<p>Read entire article: <a href="http://www.iowapolitics.com/index.iml?Article=177376" target="_blank">http://www.iowapolitics.com/index.iml?Article=177376</a></p>
<p><a id='return_to_news' href='/news/'>&laquo; Return to news items</a></p>
<div class='news_rss_feed'><a href='/category/news/feed/'><img src='/images/rss.png' alt='RSS' width='16' height='16' border='0' /> News Feed</a></div><br clear='all' />
<h3  class="related_post_title">Related Posts</h3><ul class="related_post"><li><a href="http://www.cchrint.org/2011/08/30/big-pharma-pays-us-doctors/" title="Big pharma pays US doctors $150m in 2011">Big pharma pays US doctors $150m in 2011</a> (0)</li><li><a href="http://www.cchrint.org/2011/08/05/grassley-wants-website-disclosing-conflicts-of-interest%e2%80%94letter-cites-harvard-psychiatrists-failure-to-report-nearly-1-million/" title="Grassley Wants Website Disclosing Conflicts of Interest—Letter Cites Harvard Psychiatrists Failure To Report Nearly $1 Million">Grassley Wants Website Disclosing Conflicts of Interest—Letter Cites Harvard Psychiatrists Failure To Report Nearly $1 Million</a> (0)</li><li><a href="http://www.cchrint.org/2011/06/17/beware-the-ghostwriters-of-medical-research/" title="Beware the ghost(writer)s of medical research">Beware the ghost(writer)s of medical research</a> (0)</li><li><a href="http://www.cchrint.org/2011/06/02/fda-issues-draft-guidance-for-investigator-conflicts/" title="FDA Issues Draft Guidance For Investigator Conflicts">FDA Issues Draft Guidance For Investigator Conflicts</a> (0)</li><li><a href="http://www.cchrint.org/2011/03/15/profiting-from-mental-ill-health/" title="Profiting from mental ill-health">Profiting from mental ill-health</a> (1)</li></ul>]]></content:encoded>
			<wfw:commentRss>http://www.cchrint.org/2009/11/19/grassley-demands-transparency-for-pharma-advocacy-groups/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

